BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1975458)

  • 1. [Therapy of bronchus carcinoma: therapeutic possibilities and current molecular biology trials].
    Ludwig CU
    Schweiz Med Wochenschr; 1990 Aug; 120(31-32):1143-8. PubMed ID: 1975458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined modality therapy of lung cancer.
    Livingston RB
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction to the treatment of lung cancer.
    Splinter TA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-1-S12-5. PubMed ID: 9331110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent progress and perspectives in the management of patients with lung cancer].
    Barlesi F; Gimenez C; Pibarot M; Kleisbauer JP
    Bull Cancer; 2002 Jan; 89(1):57-66. PubMed ID: 11847027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung.
    Hosoe S; Ueno K; Shigedo Y; Tachibana I; Osaki T; Kumagai T; Tanio Y; Kawase I; Nakamura Y; Kishimoto T
    Cancer Res; 1994 Apr; 54(7):1787-90. PubMed ID: 7907944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy in bronchial carcinoma].
    Manegold C; Drings P
    Schweiz Med Wochenschr; 1995 Jul; 125(29):1396-405. PubMed ID: 7545824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biology of small-cell bronchogenic carcinoma: recent advances].
    Levy R; Andrieu JM; Even P
    Bull Cancer; 1992; 79(1):25-46. PubMed ID: 1325850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined modality treatment of lung cancer: present and future].
    Ohta M; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Nov; 24(11):1186-91. PubMed ID: 3031350
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined radiotherapy and chemotherapy modalities in the treatment of lung cancer].
    Furuse K; Kawahara M; Arai R; Kodama N; Yamamoto M; Kubota K; Ogawara M; Nakai R
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1628-33. PubMed ID: 2837998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term survivors of non-small cell lung cancer treated with non-surgical therapeutic modalities].
    Fujii M; Segawa Y; Matsutomo S; Kimura M
    Gan No Rinsho; 1990 Apr; 36(5):589-92. PubMed ID: 2157905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the management of lung cancer.
    Behera D
    J Assoc Physicians India; 1991 Apr; 39(4):337-9. PubMed ID: 1657864
    [No Abstract]   [Full Text] [Related]  

  • 14. Update in the treatment and molecular biology of non-small cell lung cancer.
    Erlich R; Levitt ML
    Compr Ther; 1995 Aug; 21(8):445-57. PubMed ID: 8536445
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment based on biological characteristics of lung cancer: biological differences between small cell and non-small cell lung cancer and gene therapy].
    Tanio Y
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():337-44. PubMed ID: 9369905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer.
    Lin TS; Huang HH; Fan YH; Chiou SH; Chow KC
    Oncol Rep; 2007 Mar; 17(3):565-72. PubMed ID: 17273734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lung cancers--marking time?].
    Joss R
    Schweiz Med Wochenschr; 1983 Sep; 113(36):1256-61. PubMed ID: 6314496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity.
    Daly MC; Xiang RH; Buchhagen D; Hensel CH; Garcia DK; Killary AM; Minna JD; Naylor SL
    Oncogene; 1993 Jul; 8(7):1721-9. PubMed ID: 8390035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of small cell lung cancer].
    Ueoka H; Ohnoshi T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2571-7. PubMed ID: 7979415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.